39 results
REBEL Review 4 & 5: Paralytic & Vasopressor Dosing 

Paralytic Agents:
 - Succinylcholine (Depolarizing Agent)
& Vasopressor Dosing ... resuscitation #table ... #criticalcare # ... pharmacology #dosing ... #medications #Comparison
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
FDA-Approved 1st line Medications ... Tobacco Cessation Treatment ... , Varenicline (tablet ... release (SR) (tablet ... #Agents #Dosing
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
including tips for using ... #antibiotics #medications ... #table #treatment
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #pharmacology #treatment ... #medications #table ... hematology #warfarin #dosing
Drug Induced Kidney Injury
 • Pre-Renal: NSAIDS, CNI, ACEI/ARB, IL-2 therapy, Diuretics CAR-T therapy
 • Osmotic
@kdjhaveri #DrugInduced ... #differential #diagnosis ... #algorithm #nephrology ... #Medications
Pharmacotherapy for Migraine Prophylaxis 

Who is indicated for migraine prophylaxis? Patients who experience more than 3
appropriate acute treatment ... #Prophylaxis #Medications ... #Table #Pharmacology ... #Management #Neurology
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
pharmacology #comparison #treatment ... #medications #dosing ... #drugs #table #
Summary of Pharmacology for Select Proposed COVID-19 Treatments

#Pharmacology #Dosing #Table #COVID19 #Coronavirus #SARSCOV2 #Medications #JAMA
Proposed COVID-19 Treatments ... #Pharmacology #Dosing ... #Table #COVID19 ... Coronavirus #SARSCOV2 #Medications
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
- Differential Diagnosis ... Failure, Toxins/Medications ... #Differential #Diagnosis ... #criticalcare # ... algorithm #treatment
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... recommendations for the treatment ... the use of this medication